NCT05801913 2026-03-05Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Recruiting15 enrolled